Back to Search
Start Over
Cost-Effectiveness of Azacitidine and Ivosidenib in Newly Diagnosed Older, Intensive Chemotherapy-Ineligible Patients with IDH1-Mutant Acute Myeloid Leukemia
- Source :
- Blood; November 2022, Vol. 140 Issue: 1, Number 1 Supplement 1 p319-321, 3p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 140
- Issue :
- 1, Number 1 Supplement 1
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs62732234
- Full Text :
- https://doi.org/10.1182/blood-2022-158465